Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises ITAB in connection with a recapitalisation of SEK 868 million
Mandate

Vinge advises ITAB in connection with a recapitalisation of SEK 868 million

February 11, 2021 Capital Markets and Public M&A

The recapitalisation is carried out to strengthen ITAB’s capital structure to reduce the financial leverage of the group, to invest in the One ITAB transformation plan and to provide sufficient headroom to the business given the Covid-19 situation.

The recapitalisation entails that the equity is strengthened by approx. SEK 868 million by a rights issue of SEK 768 million and a set-off issue of SEK 100 million and entails further that Aeternum Capital becomes ITAB’s largest shareholder with a holding of approx. 25 percent of the shares. First day of trading in the new class B shares issued as a result of the recapitalisation is estimated to be 22 March 2021.

ITAB sells, develops, manufactures and installs complete shop fitting concepts for retail chain stores. The offer includes custom-made fitting concepts, innovative solutions for the checkout area, professional lighting systems and interactive products. Customers include major retail chains throughout most of Europe. ITAB’s class B shares are listed on Nasdaq Stockholm.

Vinge’s team mainly consisted of Charlotte Levin, Rikard Lindahl, Annika Nyberg Ekenberg, Clara Sohlberg, Mikaela Falkner, Henrik Wastenson and David Bokliden.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

 Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

 HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised SBP Kredit AB (publ) in connection a securitisation with a Nordic bank as senior lender

 The agreement covers a total amount of SEK 1 billion and creates conditions for significantly increased lending capacity. The agreement has been structured in accordance with the EU Securitisation Regulation and enables qualified loans to be continuously transferred to a special purpose vehicle within the SBP group.
September 14, 2026